Letter Sequence Meeting |
|---|
|
Results
Other: ML20338A160, ML20338A165, ML21026A001, ML21055A810, ML21055A820, ML21110A147, ML21110A148, ML21159A143, ML21187A126, ML21204A101, ML21309A105, ML22109A121, ML22200A061, ML22259A001, ML24040A176, ML24040A179, ML24044A062, ML24044A063
|
MONTHYEARML19221B7422019-08-30030 August 2019 Proprietary Determination Letter for ANP-10337, Revision 0, Supplement 1P, Revision 0, Deformable Spacer Grid Element RAI Response Project stage: RAI ML19347C1932019-12-10010 December 2019 Email Transmittal of Request for Additional Information Questions Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: RAI ML20083K3862020-03-26026 March 2020 Round 1 Request for Additional Information Questions for the Review of Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (Non-Proprietary) Project stage: RAI ML20338A1652020-12-10010 December 2020 Regulatory Audit Plan for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project No. 728 Project stage: Other ML20338A1602020-12-10010 December 2020 December 7 - 11, 2020, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21026A0012021-02-0909 February 2021 Audit Report Letter for Framatome Topical Report ANP-10229P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21055A8102021-03-0101 March 2021 March 3, 4, 24, 25, and 26, 2021 Regulatory Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project No. 728 EPID L-2018-TOP-0034 Project stage: Other ML21055A8202021-03-0101 March 2021 March 3, 4, 24, 25, and 26, 2021, Regulatory Audit Plan Letter for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21110A1472021-05-0404 May 2021 April 22, 2021, Audit Plan for Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (EPID L-2018-TOP-0034) (Letter) Project stage: Other ML21110A1482021-05-0404 May 2021 April 22, 2021, Audit Plan for Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21159A1432021-06-11011 June 2021 June 15, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21187A1262021-07-0909 July 2021 July 9, 2021 Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21204A1012021-07-27027 July 2021 August 11-12, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - ARTEMIS-RELAP Integrated Transient Analysis Methodology Project stage: Other ML21309A1052021-11-0808 November 2021 November 8, 2021 Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22109A1212022-04-22022 April 2022 April 20 - 21, and 28, 2022, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22097A2642022-04-26026 April 2022 U.S. Nuclear Regulatory Commissions Revised Schedule for Review of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Approval ML22200A0612022-07-25025 July 2022 Report for 2021 - 2022, Regulatory Audits Regarding Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22259A0012022-10-0505 October 2022 Schedule Change Letter for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22357A0822023-01-0909 January 2023 The U.S. Nuclear Regulatory Commissions Revised Schedule for the Review of Framatome’S Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Approval ML23006A2522023-01-17017 January 2023 Summary of Closed Hybrid Meeting with Framatome Inc. and the U. S. Nuclear Regulatory Commission for Topical Report, Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting PMNS20230079, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-01-30030 January 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23072A3862023-04-0606 April 2023 Summary of March 2, 3023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, ANP-10339P, Revision 0, ARITA-ARTEMIS/RELAP Integrated Transient Analysis Methodology Project stage: Meeting PMNS20230725, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-06-0909 June 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23177A2582023-07-10010 July 2023 Summary of June 20, 2023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting PMNS20231147, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-10-0606 October 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23233A1392023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (EPID L 2018-TOP-0034) Letter Project stage: Approval ML23299A2402023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (Appendix IV) - Non-Proprietary Project stage: Approval ML23299A2322023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology - Non-Proprietary Project stage: Approval ML23305A0642023-11-0505 November 2023 Summary of October 19, 2023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting ML24044A0632024-02-13013 February 2024 Transmittal Withholding Determination for Publication of Framatome Topical Report, ANP-10339P, Rev. 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML24044A0622024-02-13013 February 2024 Withholding Determination for Publication of Framatome Topical Report, ANP-10339P, Rev. 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML24040A1792024-04-16016 April 2024 Verification for Publication of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Topical Report Project stage: Other ML24040A1762024-04-22022 April 2024 Verification for Publication of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Transmittal (EPID L-2018-TOP-0034) - Email Project stage: Other 2022-04-26
[Table View] |
Text
July 10, 2023 MEMORANDUM TO:
Gerond A. George, Chief Licensing Projects Branch Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation FROM:
Ngola A. Otto, Project Manager
/RA/
Licensing Projects Branch Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation
SUBJECT:
SUMMARY
OF JUNE 20, 2023, CLOSED MEETING WITH FRAMATOME INC. AND THE U.S. NUCLEAR REGULATORY COMMISSION FOR TOPICAL REPORT ANP-10339P, REVISION 0, ARITA - ARTEMIS/RELAP INTEGRATED TRANSIENT ANALYSIS METHODOLOGY (EPID L-2018-TOP-0034)
On June 20, 2023, the U.S. Nuclear Regulatory Commission (NRC) staff held a closed meeting via Microsoft Teams with representatives from Framatome Inc. (Framatome). The purpose of the meeting was for the NRC staff and Framatome representatives to discuss the draft safety evaluation (SE) limitations and conditions (L&Cs) 18 and 19 for Topical Report (TR)
ANP-10339P, Revision 0, ARITA - ARTEMIS/RELAP Integrated Transient Analysis Methodology. The meeting notice is available in the Agencywide Documents Access and Management System (ADAMS) at Accession No. ML23160A106. A meeting was also held on May 4, 2023 (ADAMS Accession No. ML23137A252), where the NRC staff and Framatome representatives discussed several L&Cs including 18 and 19.
During the meeting, the NRC staff and Framatome representatives discussed L&Cs 18 and 19 technical bases, changes made since the May 4, 2023, meeting, and a path forward for the TR review. Regarding the technical discussions, Framatome representatives indicated that additional information could be provided to the NRC staff for review to modify the L&Cs.
Pertaining to the additional information, the NRC staff explained that Framatome would need to provide the additional information on the docket for review and acceptance for changes to be made to L&C 18 and 19.
CONTACT: Ngola A. Otto, NRR/DORL 301-415-6695
At the end of the meeting, the NRC staff and Framatome representatives discussed options for moving forward. The first option included proceeding with the June 22, 2023, and July 12, 2023, Advisory Committee on Reactor Safeguards (ACRS) sub-committee (SC) and full committee (FC) meetings, respectively, and then issuance of the final SE. After the final SE issuance, Framatome could then submit a minor revision/supplement to the approved ANP-10339P, Revision 0 TR. The NRC staff could then review the TR revision utilizing an expedited TR review process per the LIC-500 TR Office Instruction.
The second option included proceeding with the June 22, 2023, ACRS SC meeting and delaying the July 12, 2023, ACRS FC meeting so that additional information could be submitted on the docket and reviewed in the interim. After reviewing the additional information, then NRC staff and Framatome representatives could go back to the ACRS SC to present updated information, followed by meeting with the ACRS FC, and then issuing the final SE.
In summary, the NRC staff and Framatome representatives agreed to proceed with the June 22, 2023, ACRS SC and July 12, 2023, ACRS FC meetings and for the NRC staff to issue the final SE. Framatome will contact the NRC regarding its decision on a path forward (e.g., via a letter, revised TR, or licensing action for the NRC staff to review) to facilitate future changes to L&C 18 and 19.
A list of the attendees is enclosed. This meeting summary and other information associated with this meeting can be found at ADAMS Package Accession No. ML23173A075.
Docket No. 99902041
Enclosure:
List of Attendees
Enclosure List of Attendees Closed Meeting between Framatome Inc.
and the U.S. Nuclear Regulatory Commission to Discuss Topical Report ANP-10339P, Revision 0, ARITA - ARTEMIS/RELAP Integrated Transient Analysis Methodology June 20, 2023 10:00 am - 12:00 pm NAME ORGANIZATION Keith Maupin Framatome Inc. (Framatome)
Steven Lydzinski Framatome Alan Meginnis Framatome Buck Barner Framatome Gregory Suber U. S. Nuclear Regulatory Commission (NRC)
Chris Van Wert NRC Gerond George NRC Kevin Heller NRC Benjamin Parks NRC John Lehning NRC Ngola Otto NRC
ML23173A075 (Package)
ML23177A258 (Summary)
ML23172A199 (Presentation - Proprietary)
- via email NRR-106 OFFICE NRR/DORL/LLPB/PM*
NRR/DORL/LLPB/LA*
NRR/DORL/LLPB/BC*
NRR/DORL/LLPB/PM*
NAME NOtto DHarrison GGeorge NOtto DATE 6/28/2023 6/28/2023 7/3/2023 7/10/2023